PBMC Cryopreservation Medium, with DMSO - GMP grade

Product performance
· Protect immune cells from the source and improve the stability of cell drug R&D pipeline.
· Support direct freezing to solve the problem of complicated PBMC cryopreservation operation process and large number of cryopreserved samples.
· After cryopreservation and resuscitation, the cell viability is close to that of fresh tissue cells, the safety of cryopreservation is improved, and the recovery rate of immune cells is effectively guaranteed.
· Achieve high-density cryopreservation (100 M/mL), overcoming the problem that blood samples are precious and cannot be cryopreserved with high quality and high density.

Features
· The world's first PBMC cryopreservation solution
· Developed based on ice-controlled cryopreservation technology
· Double cryoprotectant, containing self-developed ice-controlled protectant + 10% USP-grade DMSO
· Cell recovery rate>97%
· Serum-free, protein-free, animal-free
· Full pharmacopoeia ingredients, clear components, pharmaceutical-grade raw materials
· Sterile, low endotoxin, <0.125 EU/mL
· High safety, high recovery rate, ultra-high ease of use
· Support ultra-high density cryopreservation, 1×10^6~1×10^8 cells/mL
· GMP grade
· Ready-to-use, can be stored and transported over long distances at 2~8°C
· Support direct freezing, no need for programmed cooling box (Short-term storage: -80°C freezer. For long-term storage, transfer to -196°C liquid nitrogen after 12 hours.)

Please contact us at for specific academic pricing.

More Details